Correlation between plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G polymorphism and metabolic/proinflammatory factors in polycystic ovary syndrome

By Sales MF   Sóter MO   Candido AL   Fernandes AP   Oliveira FR   Ferreira ACS   Sousa MO   Ferreira CN   Gomes KB  

Gynecological Endocrinology, Vol. 29, Iss. 10, 2013-10 ,pp. : 936-939

Informa Healthcare

Access to resources Recommend Favorite

Molecular Advances in Plasminogen Activator Inhibitor 1 Interaction with Thrombin and Tissue-Type Plasminogen Activator

By Stoop A.   van Meijer M.   Horrevoets A.J.G.   Pannekoek H.  

Trends in Cardiovascular Medicine, Vol. 7, Iss. 2, 1997-02 ,pp. : 47-51

Elsevier

Access to resources Recommend Favorite

Tissue plasminogen activator and plasminogen activator inhibitor 1 in obese and lean patients with polycystic ovary syndrome

By Lindholm Åsa   Bixo Marie   Eliasson Mats   Hudecova Miriam   Arnadottir Ragnheidur   Holte Jan   Poromaa Inger Sundström  

Gynecological Endocrinology, Vol. 26, Iss. 10, 2010-10 ,pp. : 743-748

Informa Healthcare

Access to resources Recommend Favorite

Expression of type-1 plasminogen activator inhibitor in the kidney of diabetic rat models

By Hagiwara H.   Kaizu K.   Uriu K.   Noguchi T.   Takagi I.   Qie Y.L.   Seki T.   Ariga T.  

Thrombosis Research, Vol. 111, Iss. 4, 2003-01 ,pp. : 301-309

Elsevier

Access to resources Recommend Favorite

Plasminogen Activator Inhibitor-1, Fibrinogen, and Lung Function in Adolescents with Asthma and Obesity

By Huang Fengyang   del-Río-Navarro Blanca Estela   Alcántara Saúl Torres   Ontiveros José Alfredo Pérez   Cienfuegos Dino Roberto Pietropaolo   González Santos Albel Bello   Villafaña Santiago   Bravo Guadalupe   Hong Enrique  

Endocrine Research, Vol. 37, Iss. 3, 2012-08 ,pp. : 135-144

Informa Healthcare

Access to resources Recommend Favorite